Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Thymoma and Thymic Carcinoma”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Testing effectiveness (Phase 2)Study completedNCT00003662
What this trial is testing

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Roswell Park Cancer Institute 90
Not applicableNot Yet RecruitingNCT07328074
What this trial is testing

Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis

Who this might be right for
Thymic Epithelial TumorThymomaThymic Carcinoma+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 70
Testing effectiveness (Phase 2)Looking for participantsNCT05832827
What this trial is testing

First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)

Who this might be right for
Untreated Advanced or Recurrent Thymic Carcinomas
National Cancer Center, Japan 35
Not applicableActive Not RecruitingNCT03968315
What this trial is testing

An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma

Who this might be right for
Recurrent Malignant ThymomaThymoma
M.D. Anderson Cancer Center 40
Early research (Phase 1)Study completedNCT00066404
What this trial is testing

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Who this might be right for
Cancer
Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Study completedNCT03102320
What this trial is testing

Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors

Who this might be right for
Neoplasms
Bayer 173
Not applicableLooking for participantsNCT06301945
What this trial is testing

Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors

Who this might be right for
Thymic Epithelial TumorThymic CarcinomaThymoma+1 more
Erasmus Medical Center 1,020
Testing effectiveness (Phase 2)UnknownNCT03663764
What this trial is testing

Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor

Who this might be right for
Thymoma and Thymic Carcinoma
Sun Yat-sen University 57
Testing effectiveness (Phase 2)Study completedNCT00024076
What this trial is testing

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaMetastatic Cancer+1 more
Jonsson Comprehensive Cancer Center 30
Not applicableStudy completedNCT04662645
What this trial is testing

Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their Caregivers

Who this might be right for
CaregiverMalignant Pleural NeoplasmMetastatic Thymic Carcinoma+9 more
Ohio State University Comprehensive Cancer Center 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT04417660
What this trial is testing

Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma

Who this might be right for
Thymic Epithelial TumorRecurrent ThymomaThymic Cancer
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT02021942
What this trial is testing

Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size

Who this might be right for
Primary Inoperable ThymomaLocal Recurrent Thymoma
Prof. Dr. Berthold Schalke 16
Testing effectiveness (Phase 2)Ended earlyNCT00718809
What this trial is testing

Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer

Who this might be right for
Invasive Thymoma and Thymic CarcinomaRecurrent Thymoma and Thymic CarcinomaStage III Thymoma+2 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT02623127
What this trial is testing

Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma

Who this might be right for
Thymic Carcinoma
Seoul National University Hospital 25
Testing effectiveness (Phase 2)Study completedNCT00003283
What this trial is testing

Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma

Who this might be right for
Thymoma and Thymic Carcinoma
Eastern Cooperative Oncology Group 38
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00387868
What this trial is testing

Preoperative Treatment of Patients With High Risk Thymoma

Who this might be right for
Thymoma
Valley Health System 21
Testing effectiveness (Phase 2)Ended earlyNCT01100944
What this trial is testing

PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies

Who this might be right for
ThymomaThymic Carcinoma
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Study completedNCT03694002
What this trial is testing

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Locally Advanced Thymic CarcinomaMetastatic Thymic CarcinomaRecurrent Thymic Carcinoma+1 more
SWOG Cancer Research Network 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT01025089
What this trial is testing

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

Who this might be right for
ThymomaThymic CarcinomaClinical Masaoka Stage II to IVA
Memorial Sloan Kettering Cancer Center 18
Load More Results